Successful management of a triplet heterotopic caesarean scar pregnancy after in vitro fertilization-embryo transfer

被引:38
作者
Litwicka, Katarzyna [1 ]
Greco, Ermanno [1 ]
Prefumo, Federico [2 ]
Fratelli, Nicola [2 ]
Scarselli, Filomena [1 ]
Ferrero, Susanna [1 ]
Iammarrone, Elisabetta [1 ]
Frusca, Tiziana [2 ]
机构
[1] European Hosp, Assisted Reprod Ctr, I-00149 Rome, Italy
[2] Univ Brescia, Maternal Fetal Med Unit, Brescia, Italy
关键词
Caesarean scar pregnancy; heterotopic pregnancy; embryo reduction; potassium chloride; methotrexate; INTRAUTERINE; REDUCTION; INJECTION; PRESERVATION;
D O I
10.1016/j.fertnstert.2010.05.025
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To report a case of a triplet heterotopic caesarean scar pregnancy (CSP) with two gestational sacs implanted in the caesarean scar after in vitro fertilization-embryo transfer. Design: Case report. Settings: Private reproductive medicine center and obstetric department of a university hospital. Patient(s): A 31-year-old woman with previous caesarean section affected by secondary infertility related to male azoospermia. Intervention(s): In vitro fertilization-embryotransfer followed by early ultrasound diagnosis of heterotopic CSP and selective embryo reduction performed by transvaginal ultrasound-guided potassium chloride and methotrexate injection in the ectopic gestational sacs. Main outcome mesure(s): Successful pregnancy outcome. Result(s): An ongoing intrauterine pregnancy with a live birth after successful management of ectopic gestational sacs. Conclusion(s): Triplet heterotopic CSP with two ectopic gestational sacs may occur after IVF-ET and, to our knowledge, this is the first time such a complication has been reported. Ultrasound is the main tool allowing early diagnosis of this condition, and the injection of potassium chloride and methotrexate is a safe and efficacious treatment method. The gynecologist managing early pregnancy should be aware of the possibility of CSP, and patients must be appropriately counseled about the different treatment options. (Fertil Steril (R) 2011;95:291.e1-e3. (C) 2011 by American Society for Reproductive Medicine.)
引用
收藏
页码:291.e1 / 291.e3
页数:3
相关论文
共 21 条
[1]
Methotrexate/misoprostol embryopathy: Report of four cases resulting from failed medical abortion [J].
Adam, MP ;
Manning, MA ;
Beck, AE ;
Kwan, A ;
Enns, GM ;
Clericuzio, C ;
Hoyme, HE .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 123A (01) :72-78
[2]
Al-Azemi Majedah, 1999, Hum Fertil (Camb), V2, P67, DOI 10.1080/1464727992000198341
[3]
Caesarean scar pregnancy [J].
Ash, A. ;
Smith, A. ;
Maxwell, D. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 114 (03) :253-263
[4]
Transvaginal reduction of an interstitial heterotopic pregnancy with preservation of the intrauterine gestation [J].
Baker, VL ;
Givens, CR ;
Cadieux, MCM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (06) :1384-1385
[5]
Heterotopic pregnancy: two cases and a comparative review [J].
Barrenetxea, Gorka ;
Barinaga-Rementeria, Lorea ;
Lopez de Larruzea, Arantza ;
Ander Agirregoikoa, Jon ;
Mandiola, Miren ;
Carbonero, Koldo .
FERTILITY AND STERILITY, 2007, 87 (02) :417.e9-417.e15
[6]
Laparoscopic management of heterotopic cesarean scar pregnancy with preservation of intrauterine gestation and delivery at term: case report [J].
Demirel, L. Cem ;
Bodur, Harika ;
Selam, Belgin ;
Lembet, Arda ;
Ergin, Tolga .
FERTILITY AND STERILITY, 2009, 91 (04) :1293.e5-1293.e7
[7]
Failed methotrexate termination of pregnancy: a case report [J].
Goffman, D. ;
Cole, D. S. ;
Bobby, P. ;
Garry, D. J. .
JOURNAL OF PERINATOLOGY, 2006, 26 (10) :645-647
[8]
Transvaginal local injection of Hyperosmolar glucose for the treatment of heterotopic pregnancies [J].
Goldberg, Jeffrey M. ;
Bedaiwy, Mohamed A. .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (02) :509-510
[9]
Maternal complication of cervical heterotopic pregnancy after successful potassium chloride fetal reduction [J].
Gyamfi, C ;
Cohen, S ;
Stone, JL .
FERTILITY AND STERILITY, 2004, 82 (04) :940-943
[10]
Honda Ritsuo, 2005, Reprod Med Biol, V4, P221, DOI 10.1111/j.1447-0578.2005.00109.x